Labiotech.eu

News and Trends 22 Jan 2018

No More Mosquito Bites? Targeting These Genes Could Prevent Future Outbreaks!

Researchers may have found a way to stop the female mosquitoes from biting you, which could help to prevent the spread of diseases like malaria. Scientists at the University of Birmingham in the UK and the University of Notre Dame in Paris, along with collaborators in the US, have identified 902 genes specific to blood-feeding mosquitoes […]

January 22, 2018 - 3 minutesmins - By Alex Dale

Interview 22 Jan 2018

Bravo! An Interview with the CEO of Takeda’s Recent Cell Therapy Target

I sat down with Eduardo Bravo, CEO of TiGenix, to talk about the technology that made his company so attractive to the pharma giant. After beginning his career in big pharma, Eduardo Bravo took the plunge into biotech in 2005 when he saw the opportunity for a breakthrough therapy at a small Spanish biotech called […]

January 22, 2018 - 6 minutesmins - By Evelyn Warner

origin of life bioluminescence protocell

More News! 20 Jan 2018

These Artists Recreate the Origins of Life with Bioluminescence

Evelina Domnitch and Dmitry Gelfand explore the origin of life by creating protocell bioluminescence that evokes the early forms of life on Earth. The origin of life is still a bit of a mystery. Scientists have narrowed it down to a series of processes that must have occurred billions of years ago for life to […]

January 20, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 19 Jan 2018

The European Patent Office Revokes the Broad Institute‘s CRISPR Patents

The Broad Institute has been dealt a big blow in its battle for CRISPR/Cas9 intellectual property, with the European Patent Office revoking one of its patents. CRISPR/Cas9 has been hailed as the ‘scientific discovery of the century’ due to its capacity to modify the genome for the treatment of genetic diseases. The Broad Institute, set up by MIT […]

January 19, 2018 - 3 minutesmins - By Alex Dale

News and Trends 18 Jan 2018

France Gets Ready to Test CAR-Treg Cells to Avoid Transplant Rejection

TxCell has received a €1.2 loan from Bpifrance to complete preclinical trials with its CAR-Treg technology for transplant rejection and start human testing. French biotech TxCell is finalizing the preparations to take its first cell therapy to clinical trials. The treatment, called HLA-A2 CAR-Treg, is intended for the prevention of chronic rejection after organ transplantation. […]

January 18, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jan 2018

Meet the 10 Promising Synbio Startups in RebelBio’s London Cohort

Irish accelerator RebelBio has launched its latest cohort of startups that will receive its support during a 3-month program at Imperial College London. RebelBio is a startup accelerator that helps entrepreneurs to build technology associated with the life sciences field. It offers seed funding, lab space, mentorship, and a community of successful and diverse founders […]

January 18, 2018 - 4 minutesmins - By Alex Dale

autoimmune diseases psoriasis arthritis 1

News and Trends 18 Jan 2018

This Cytokine is Key to Autoimmune and Inflammatory Diseases

An international group of researchers has found that the cytokine IL-23 is heavily involved in autoimmune and inflammatory diseases, opening the door to new therapies targeting the molecule. Research at the VIB-UGent Center for Inflammation Research has identified a crucial molecular mechanism underlying autoimmune and inflammatory diseases like psoriasis, rheumatoid arthritis, and multiple sclerosis. The study, […]

January 18, 2018 - 3 minutesmins - By Alex Dale

More News! 18 Jan 2018

First Patient Successfully Implanted with Heart Valve Replacement Device

French company Kephalios has successfully implanted a new adjustable device to repair a heart valve defect in a human patient for the first time. The first of five patients in a clinical trial at the Vienna General Hospital has received an implant designed to repair mitral valve regurgitation. This disease causes the mitral valve to not close properly […]

January 18, 2018 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 18 Jan 2018

Report from JP Morgan 2018: Taking the Financial Temperature of Biotech

As heard at JP Morgan 2018, last year was an ok year for biotech. But how does 2018 look? Here are the thoughts of a panel convened to discuss the numbers. A biotech whirlwind swept through San Francisco last week as the industry descended on Union Square for the JP Morgan Healthcare Conference of 2018. […]

January 18, 2018 - 5 minutesmins - By Evelyn Warner

News and Trends 17 Jan 2018

French Biotech Closes a €18.5M Series B to Boost Colon Cancer Diagnostics

HalioDx hopes that its Immunoscore diagnostics platform can help to provide precision medicine for a number of indications, including colon cancer. HalioDx is an expert in cancer diagnostics, specializing in the analysis of the tumor microenvironment. The company has closed a €18.5M Series B financing round – impressive considering the concerns over reimbursement that investors often have for diagnostic […]

January 17, 2018 - 3 minutesmins - By Alex Dale

owkin artificial intelligence drug development

More News! 17 Jan 2018

€9M Round for AI Algorithms to Speed up Drug Development

Owkin has raised $11M(€9M) in a Series A round to fund its artificial intelligence platform for medical research and drug discovery. Owkin, based in New York and Paris, was founded in 2016 to develop machine learning algorithms that can deal with the overabundance of information in biology to optimize the drug development process. The company […]

January 17, 2018 - 2 minutesmins - By Clara Rodríguez Fernández

More News! 17 Jan 2018

This French Biotech is Developing Kits to Stop Food Poisoning

Novolyze has raised €2.2M to bring its ready-to-use food safety kits to market as quickly as possible and help the hundreds of millions of people affected by food poisoning each year. Novolyze is a French biotech that develops products and services to reduce the risk of foodborne infections. It has raised €2.2M to accelerate its growth in markets […]

January 17, 2018 - 3 minutesmins - By Alex Dale

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

No More Mosquito Bites? Targeting These Genes Could Prevent Future Outbreaks!

Bravo! An Interview with the CEO of Takeda’s Recent Cell Therapy Target

These Artists Recreate the Origins of Life with Bioluminescence

The European Patent Office Revokes the Broad Institute‘s CRISPR Patents

France Gets Ready to Test CAR-Treg Cells to Avoid Transplant Rejection

Meet the 10 Promising Synbio Startups in RebelBio’s London Cohort

This Cytokine is Key to Autoimmune and Inflammatory Diseases

First Patient Successfully Implanted with Heart Valve Replacement Device

Report from JP Morgan 2018: Taking the Financial Temperature of Biotech

French Biotech Closes a €18.5M Series B to Boost Colon Cancer Diagnostics

€9M Round for AI Algorithms to Speed up Drug Development

This French Biotech is Developing Kits to Stop Food Poisoning

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!